{"public_id":"co_00bd6a8952537ead98fa23117cc1cb6a","status":"active","merged_into_public_id":null,"resolved_public_id":"co_00bd6a8952537ead98fa23117cc1cb6a","name":"risperidone long-acting injection","description":"A long-acting injectable form of risperidone used to treat schizophrenia.","aliases":["RLAI"],"types":["treatment"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":22471512,"title":"Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients","citation_count":9,"url":"https://sah.borca.ai/papers/22471512"}],"claims":[{"public_id":"cl_13bf3742a9d79d4a57b6fb82ac030fc9","text":"No statistically significant difference was found between paliperidone palmitate and risperidone long-acting injection for length of stay on initial hospitalization.","corpus_id":22471512,"url":"https://sah.borca.ai/claims/cl_13bf3742a9d79d4a57b6fb82ac030fc9"},{"public_id":"cl_5e51be55f0f32e5e213303d86849f7f6","text":"A trend favored paliperidone palmitate for time to treatment discontinuation, but the result was affected by patients switching between the two injections.","corpus_id":22471512,"url":"https://sah.borca.ai/claims/cl_5e51be55f0f32e5e213303d86849f7f6"},{"public_id":"cl_db7db9e0d2058d1b31b5c0da5f9991a4","text":"Time to first rehospitalization was similar for paliperidone palmitate and risperidone long-acting injection.","corpus_id":22471512,"url":"https://sah.borca.ai/claims/cl_db7db9e0d2058d1b31b5c0da5f9991a4"},{"public_id":"cl_de239408f194f797039c894fde330f03","text":"Patients receiving paliperidone palmitate were more likely than those receiving risperidone long-acting injection to have nonpsychiatric comorbidities, prior antipsychotic therapy, and psychiatric hospitalization in the previous year.","corpus_id":22471512,"url":"https://sah.borca.ai/claims/cl_de239408f194f797039c894fde330f03"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_00bd6a8952537ead98fa23117cc1cb6a","url":"https://sah.borca.ai/concepts/co_00bd6a8952537ead98fa23117cc1cb6a"}